Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Terrascend Corp TSNDF


Primary Symbol: T.TSND

TerrAscend Corp. is a Canada-based cannabis company. The Company has vertically integrated licensed operations in Pennsylvania, New Jersey, Maryland, Michigan and California through TerrAscend Growth Corp. and retail operations in Canada through TerrAscend Canada Inc. (TerrAscend). TerrAscend operates The Apothecarium, Gage and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing product selection to both the medical and legal adult-use markets. The Company a variety of product types including flower, vaporizable, concentrates, topicals, tinctures, and edibles. The Company owns or licenses several synergistic businesses and brands including Gage Cannabis, The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections.


TSX:TSND - Post by User

Comment by proneon Sep 22, 2021 6:38am
145 Views
Post# 33897135

RE:The United States Supreme Court

RE:The United States Supreme CourtAND ---> As Bernie Sanders states ---> This session, advocates are focused on a marijuana descheduling bill that’s being led by Senate Majority Leader Chuck Schumer (D-NY), Senate Finance Committee Chairman Ron Wyden (D-OR) and Sen. Cory Booker (D-NJ).

After introducing a discussion draft of the legislation in July, the senators opened a comment period to get public input on its provisions before the bill is finalized.

That comment window closed on Wednesday, and much of the feedback focused on issues of social equity, licensing, tax policy and interstate commerce.

There have been some serious questions about whether the senators will be able to muster the 60 votes needed to pass the legislation in their chamber.

Even with a slim Democratic majority in the Senate, there are some members of Schumer’s own party who’ve expressed concerns about the comprehensive reform.

President Joe Biden’s position on cannabis presents another complication. Minutes after the senators unveiled the bill, White House Press Secretary Jen Psaki was asked at a briefing about the administration’s position on the legislation and said “nothing has changed” with respect to Biden’s opposition to adult-use legalization.

Sanders said ---> last month that Biden ---> could and ---> should use executive authority to end federal marijuana prohibition on his own—but the two of them have “differences” when it comes to drug policy.

As a Democratic presidential candidate in 2020 himself,
---> Sanders pledged that he would legalize marijuana across the country on his first day in office if elected.

<< Previous
Bullboard Posts
Next >>